← Leaderboards
Gang Liu
University Of Alabama At Birmingham
$12,948,801
Attributed
$13,462,238
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2010–25$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,462,238 · 8
By mechanism
R35$5,197,500 · 1
R01$4,947,055 · 4
P01$1,887,934 · 1
R42$1,026,874 · 1
R21$402,875 · 1
Top collaborators
- Jenny J Yang1 shared
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Veena B Antony$12,946,743
- Bernard Roizman$20,026,247
- Candece L Gladson$9,713,401
- Garrett Joseph Brinkley$162,631
- Om Prakash Srivastava$7,222,144
Others in their field
Top investigators on “Lung”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$372,040,227
- Chanza Baytop · Westat, Inc.$271,217,917
- Richard K. Wilson · Washington University$201,818,043
- Walter John Curran · Thomas Jefferson University$112,093,071
Research focus
LungPathogenesisIn VivoEffective TherapyPulmonary FibrosisMicrornasPhenotypeSeveritiesRegulationPlayAffectLung InjuryProteinsCellsSolidFoundationsMediatingLung DiseasesEventPathway InteractionsNovel TherapeuticsNovel Therapeutic InterventionHamman-Rich SyndromeCardiovascular Diseases
Grant awards (27)
Precision MRI with Protein Contrast Agent for Noninvasive Detection of Lung Fibrosis$1,026,874
R42 · FY2025 · HL
Mechanism and targeting of inflammasome activation in lung inflammation and injury$553,963
R01 · FY2025 · AI · contact PI
Mechanism and targeting of inflammasome activation in lung inflammation and injury$571,095
R01 · FY2024 · AI · contact PI
Program on cellular metabolism and lung fibrosis$742,500
R35 · FY2023 · HL · contact PI
Mechanism and targeting of inflammasome activation in lung inflammation and injury$571,095
R01 · FY2023 · AI · contact PI
Program on cellular metabolism and lung fibrosis$742,500
R35 · FY2022 · HL · contact PI
Program on cellular metabolism and lung fibrosis$742,500
R35 · FY2021 · HL · contact PI
Program on cellular metabolism and lung fibrosis$742,500
R35 · FY2020 · HL · contact PI
Program on cellular metabolism and lung fibrosis$742,500
R35 · FY2019 · HL · contact PI
Program on cellular metabolism and lung fibrosis$742,500
R35 · FY2018 · HL · contact PI
Program on cellular metabolism and lung fibrosis$742,500
R35 · FY2017 · HL · contact PI
miR-31 as a Negafive Regulator of Pulmonary Fibrosis$375,262
P01 · FY2017 · HL · contact PI
miR-31 as a Negafive Regulator of Pulmonary Fibrosis$375,262
P01 · FY2016 · HL · contact PI
Metabolic reprogramming in myofibroblasts as a mechanism of pulmonary fibrosis$367,500
R01 · FY2016 · HL · contact PI
miR-31 as a Negafive Regulator of Pulmonary Fibrosis$384,111
P01 · FY2015 · HL · contact PI
miR-21 and lung fibrosis$360,756
R01 · FY2015 · HL · contact PI
miR-31 as a Negafive Regulator of Pulmonary Fibrosis$382,162
P01 · FY2014 · HL · contact PI
miR-21 and lung fibrosis$358,925
R01 · FY2014 · HL · contact PI
miR-31 as a Negafive Regulator of Pulmonary Fibrosis$371,137
P01 · FY2013 · HL · contact PI
miR-21 and lung fibrosis$348,670
R01 · FY2013 · HL · contact PI
Urokinase, Neutrophil Activation and Acute Lung Injury.$344,936
R01 · FY2013 · HL · contact PI
miR-21 and lung fibrosis$366,250
R01 · FY2012 · HL · contact PI
Urokinase, Neutrophil Activation and Acute Lung Injury.$362,328
R01 · FY2012 · HL · contact PI
Urokinase, Neutrophil Activation and Acute Lung Injury.$375,287
R01 · FY2011 · HL · contact PI
miR-21 and lung fibrosis$366,250
R01 · FY2011 · HL · contact PI
MicroRNAs, inflammation, and acute lung injury.$219,750
R21 · FY2011 · HL · contact PI
MicroRNAs, inflammation, and acute lung injury.$183,125
R21 · FY2010 · HL · contact PI